drugset / Trial / NCT07138378
A Bioavailability Study of Nilotinib in Healthy, Adult, Human Subjects Under Fasted Conditions.
RandomizedCrossoverOpen-labelTreatment
Summary
An open label, single-center, balanced, randomized, four-treatment, four-sequence, four-period, single dose, crossover, comparative bioavailability study in healthy, adult, human subjects under fasteding conditions
Timeline
- Start
- 2024-11-15
- Primary completion
- 2024-12-15
- Completion
- 2024-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nilotinib | Small molecule | 96 mg | — |
| Subject | Nilotinib | Small molecule | 192 mg | — |
| Subject | Nilotinib | Small molecule | 200 mg | — |
| Subject | Nilotinib | Small molecule | 400 mg | — |